• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CYCC

CYCC

Cyclacel Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD6.37

-0.41 (-5.98%)

Company Profile

CEO

Sing Ee Wong

IPO Date

2004-03-16

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$6.76

Prev. Close

$6.77

Day Low

$6.10

Day High

$6.96

52W Low

$3.08

52W High

$597.60

Market Cap

$0.01B

Volume

0.22M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

51.4%

Avg Negative

17.9%

Avg Neutral

30.6%

News Feed

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Stock Passes Above 200 Day Moving Average of $2.43

https://www.thelincolnianonline.com·7/14/2020·↑ positive

VITRAC Therapeutics Initiated Global Clinical Development of VIC-1911, licensed from Taiho Pharmaceutical

businesswire·6/29/2020·↑ positive

CDK Global Inc (NASDAQ:CDK) Shares Bought by Nuveen Asset Management LLC

https://www.thelincolnianonline.com·6/17/2020·↑ positive

CDK Global Inc (NASDAQ:CDK) Shares Sold by Alliancebernstein L.P.

https://www.thelincolnianonline.com·6/15/2020·↓ negative

CDK Global Inc (NASDAQ:CDK) Shares Acquired by Pictet Asset Management Ltd.

https://www.thelincolnianonline.com·6/14/2020·↑ positive

Edited Transcript of CYCC earnings conference call or presentation 12-May-20 8:30pm GMT

Yahoo·6/9/2020·↓ negative

AWS CDK for Beginners

https://medium.com·5/23/2020·↑ positive

Cyclacel Pharma Shares Spike To Session High, Up 4.6%; Hearing Research Firm Brookline Initiated Coverage On Stock With Buy Rating, $22 Price Target

Benzinga Newsdesk·5/19/2020·↑ positive

Cyclacel Pharmaceuticals Q1 EPS $(2.770) Beats $(2.900) Estimate

Benzinga Newsdesk·5/12/2020·↑ positive

Cyclacel Pharmaceuticals On April 29, Was Notified By Nasdaq That Co Has Evidenced Full Compliance With All Criteria For Continued Lisiting

Benzinga Newsdesk·5/4/2020·↑ positive